This article was originally presented as an independent educational activity under the direction of CME LLC. The ability to receive CME credits has expired. The article is now presented here for your reference. CME LLC is no longer responsible for the presentation of the article.
A 62-year-old woman presents with epistaxis from the right nostril. The nosebleed has lasted about 90 minutes, and she has become alarmed by the amount of blood on the tissues and washcloth she has applied to her nose. She denies headache, sinusitis, facial pain, diplopia, and chronic rhinorrhea.
She has had a mild upper respiratory tract infection (URTI), from which she is recovering, but otherwise she was previously in good health. At her annual physical examination 2 weeks earlier, new, mild hypertension (142/90 mm Hg) was diagnosed; lisinopril and low-dose aspirin (ASA) were prescribed. Since she did not have “baby” ASA at home, she has been using standard adult tablets instead.
She has had 3 children by vaginal delivery, extractions of permanent teeth, and a cholecystectomy—all without abnormal bleeding. She has no symptoms of heart failure.
Heart rate is 90 beats per minute and blood pressure, 150/96 mm Hg. Examination of the head, eyes, ears, nose, and throat reveals no sign of any cranial neuropathy. There are bruises on the dorsum of the patient’s right hand and on her left shin, but all other physical findings are normal.
LABORATORY RESULTS ON ADMISSION
Hemoglobin level is 13 g/dL; white blood cell count and platelet count are normal. A chemistry panel and ECG are normal as well. Prothrombin time (PT) and partial thromboplastin time (PTT) are normal; a template bleeding time is 6.5 minutes (normal, 2 to 7 minutes).
Which of the following is most likely responsible for this patient’s epistaxis?
1. Schlosser RJ. Clinical practice. Epistaxis. N Engl J Med. 2009;360:784-789.
2. Gifford TO, Orlandi RR. Epistaxis. Otolaryngol Clin North Am. 2008;41:
3. Fuchs FD, Moreira LB, Pires CP, et al. Absence of association between hypertension
and epistaxis: a population-based study. Blood Press. 2003;12:145-148.
4. Awan MS, Iqbal M, Imam SZ. Epistaxis: when are coagulation studies justified?
Emerg Med J. 2008;25:156-157.
5. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin
in the primary prevention of cardiovascular disease in women. N Engl J Med.
6. Becker RC, Meade TW, Berger PB, et al; American College of Chest
Physicians. The primary and secondary prevention of coronary artery disease:
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
(8th Edition). Chest. 2008;133(6 suppl):776S-814S.